In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

WellGen, Inc.

Latest From WellGen, Inc.

Start-Up Previews (5/03)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, Nutrigenomics, features profiles of AlphaGenics Inc., NutraGenomics Inc. and WellGen Inc. Plus these Start-Ups across Health Care: Crystalplex Corp., GlycoFi Inc., NDO Surgical Inc. and Serenex Inc.

Nutrigenomics Start-Ups

Paths to commercialization are uncertain in nutrigenomics, an emerging science which seeks to identify gene-food interactions that differ among subpopulations and between individuals and to personalize diets to prevent disease.

BioPharmaceutical Platform Technologies

WellGen Inc.

These days, consumers reach for calcium-fortified orange juice to keep bones healthy, whole-grain Cheerios that reduce the risk of heart disease and cancer, and bags of walnuts that advertise Omega 3, for heart health. The founders of WellGen believe the time is right to push the frontier of food science into medicine. With a patent from Rutgers University, WellGen will screen food substances against genes implicated in diseases.

BioPharmaceutical Platform Technologies
See All

Company Information

  • Industry
  • Research, Analytical Equipment & Supplies
  • Pharmaceuticals
    • Nutraceuticals
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
UsernamePublicRestriction

Register